First drug to treat peanut allergies in children approved in US

The US has approved a drug which aims to eliminate peanut allergies in children aged four to 17.

The treatment, called AR101, will be sold under the brand name Palforzia.

The drug has been designed to gradually reduce sensitivity to peanuts by exposing patients to a highly-refined version of peanut flour over the course of several months.

The oral treatment will be the first to offer relief from peanut allergy symptoms for those who previously had to avoid all contact with the nuts in any form, or risk a reaction requiring emergency treatment with an EpiPen or another epinephrine shot.

The US Food and Drug Administration (FDA) approved the treatment on Friday.

Mark Gibson

Graduates in Northwestern University, Evanston, Illinois 1990. Move to Los Angeles California in 2004. Specialized in Internet journalism.

Leave a Reply

Your email address will not be published. Required fields are marked *